Table 2.
Intention to use an SIS in Ottawa; no. (and %) of participantb | |||
---|---|---|---|
Characteristicc | Yes | No | OR (and 95 %CI)d |
n = 205 | n = 67 | ||
Age | 42.0 | 44.0 | p value = 0.04 |
Sexual identity | |||
LGBTQ | 29 (93.5) | 2 (6.5) | 5.61 (1.30–24.19) |
Straight | 168 (72.1) | 65 (27.9) | |
Injects with other people | |||
Yes | 176 (80.0) | 44 (20.0) | 3.23 (1.66–6.27) |
No | 26 (55.3) | 21 (44.7) | |
Injects in public | |||
Yes | 81 (82.7) | 17 (17.3) | 1.98 (1.06–3.70) |
No | 113 (70.6) | 47 (29.4) | |
Assistance to inject | |||
Yes | 81 (81.8) | 18 (18.2) | 1.84 (1.00–3.38) |
No | 120 (71.0) | 49 (29.0) | |
Last hep C test | |||
Positive | 129 (80.1) | 32 (19.9) | 2.13 (1.16–3.91) |
Negative | 51 (65.4) | 27 (34.6) | |
Overdosed | |||
Yes | 66 (83.5) | 13 (16.5) | 2.00 (1.02–3.92) |
No | 137 (71.7) | 54 (28.3) |
OR odds ratio, CI confidence interval
aPercentages are calculated on the basis of the sum across each row
bExcept where indicated otherwise. Because of missing responses, the data for some characteristics do not sum to 272
cVariables are reported for the previous 12 months unless otherwise specified
dFor each categorical variable, the reference category is the second category